Côte d'Ivoire

Reimbursed Care Access

In Côte d'Ivoire the only psychedelic/psychoactive compound with an established, routine medical role and inclusion on the national essential medicines list is ketamine (used as an anesthetic). Other classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, etc.), as well as newer research-stage compounds, have no described national medical reimbursement framework and are effectively restricted to tightly controlled research or remain prohibited under international psychotropic drug controls that Côte d’Ivoire is party to. Esketamine (Spravato) and approved, reimbursed psychedelic-assisted programs are not documented in national health policy or reimbursement sources.